Navigated micropulse laser for central serous chorioretinopathy: Efficacy, safety, and predictive factors of treatment response.

/ Publications / Navigated micropulse laser for central serous chorioretinopathy: Efficacy, safety, and predictive factors of treatment response.

Navigated micropulse laser for central serous chorioretinopathy: Efficacy, safety, and predictive factors of treatment response.

Authors: Amoroso, F., Pedinielli, A., Cohen, S. Y., Jung, C., Chhablani, J., Astroz, P., ... & Miere, A.
Presented: January 1, 2021
Type: Publications

Related publications and webinars

From Minimally Invasive Procedure to Photocoagulation: Personalized retinal care with Navilas® (Japanese)

  • Type:
  • Presented:February 8, 2024
Priv.-Doz. Dr. med. Yoko Miura

On-Demand Webinar: Navilas in der täglichen Praxis

  • Type:
  • Presented:February 1, 2017
Dr. Bernd Fassebender
  • The treatment strategy and selected parameters presented in content listed here are solely the responsibility of the treating ophthalmologist, who is required to be familiar with the most recent literature/guidelines or recommendations, as well as with the usage of the Navilas Laser System according to the current Operator’s Manual.